In this study, miR-129’s predicted regulation of COL1A1 underscores its potential role in extracellular matrix remodeling and tumor invasiveness, particularly in aggressive subtypes like TNBC and Non-luminal HER2+ breast cancer. Here, ERBB2 is linked to breast carcinoma.